First European phase II trial of intravenous (iv) cetuximab (Cet) and hepatic artery infusion (HAI) of irinotecan, 5-fluorouracil and oxaliplatin in patients with unresectable liver metastases from wt KRAS colorectal cancer (CRC) after systemic therapy failure (OPTILIV, NCT00852228)

被引：0
|
作者：
Levi, Francis
Ducreux, Michel
Hebbar, Mohamed
Rougier, Philippe
Focan, C. N. J.
Guimbaud, Rosine
Carvalho, Carlos
Tumolo, Salvatore
Innominato, Pasquale F.
Ajavon, Yves
Castaing, Denis
De Baere, Thierry
Karaboue, Abdoulaye
Lepere, Celine
Boige, Valerie
Proux, Laetitia
Adam, Rene
Bouchahda, Mohamed
机构：
[1] Hop Paul Brousse, Dept Med Oncol, INSERM U776, Villejuif, France
[2] Inst Gustave Roussy, Villejuif, France
[3] Ctr Hosp Reg & Univ Lille, Hop Huriez, Med Oncol Unit, F-59037 Lille, France
[4] European Hosp George Pompidou, Paris, France
[5] CHC Clin St Joseph, Liege, Belgium
[6] Univ Hosp Purpan, Toulouse, France
[7] Hosp Fernando Fonesca Amadora, Med Oncol Unit, Amadora, Portugal
[8] Santa Maria Degli Angeli Gen Hosp, Pordenone, Italy
[9] Hop Paul Brousse, Inserm U776, Dept Cancerol, Villejuif, France
[10] Hop Paul Brousse, Serv Radiol, Villejuif, France
[11] Hop Paul Brousse, Hepatobiliary Ctr, Villejuif, France
[12] Hop Paul Brousse, INSERM U776, Villejuif, France
[13] Inst Gustave Roussy, Serv Hepatogastroenterol, Villejuif, France
[14] CRESGE, Lille, France
[15] Hop Paul Brousse, Hepatobiliary Ctr, Villejuif, France
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3547
引用
收藏
页数：1
相关论文
共 33 条
  • [21] Phase I trial of hepatic arterial infusion (HAI) of floxuridine with modified oxaliplatin, 5-fluorouracil and leucovorin (m-FOLFOX6) in Chinese patients with unresectable liver metastases from colorectal cancer
    Li, Cong
    Gu, Yangkui
    Zhao, Ming
    Yuan, Yunfei
    Wang, Fenghua
    Wang, Zhiqiang
    Li, Wang
    Luo, Huiyan
    Chen, Cui
    Chen, Gong
    Ding, Peirong
    Wu, Xiaojun
    Lu, Zhenhai
    Pan, Zhizhong
    Xu, Ruihua
    He, Youjian
    Wan, Desen
    Li, Yuhong
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2014, 74 (05) : 1079 - 1087
  • [22] Hepatic arterial infusion of oxaliplatin and intravenous LV5FU2 in unresectable liver metastases from colorectal cancer after systemic chemotherapy failure
    Boige, Valerie
    Malka, David
    Elias, Dominique
    Castaing, Marine
    De Baere, Thierry
    Goere, Diane
    Dromain, Clarisse
    Pocard, Marc
    Ducreux, Michel
    ANNALS OF SURGICAL ONCOLOGY, 2008, 15 (01) : 219 - 226
  • [23] Hepatic Arterial Infusion of Oxaliplatin and Intravenous LV5FU2 in Unresectable Liver Metastases from Colorectal Cancer after Systemic Chemotherapy Failure
    Valérie Boige
    David Malka
    Dominique Elias
    Marine Castaing
    Thierry De Baere
    Diane Goere
    Clarisse Dromain
    Marc Pocard
    Michel Ducreux
    Annals of Surgical Oncology, 2008, 15 : 219 - 226
  • [24] Pharmacokinetic-pharmacodynamic analysis of hepatic artery infusion of three-drug chronomodulated chemotherapy and intravenous cetuximab in patients with liver metastases from colorectal cancer registered in OPTILIV, a European multicenter phase II trial
    Levi, F.
    Karaboue, A.
    Etienne-Grimaldi, M.
    Chatelut, E.
    Innominato, P. F.
    Paintaud, G.
    Loukakos, P.
    Adam, R.
    Bouchahda, M.
    Milano, G.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [25] HEPATIC ARTERIAL INFUSION (HAI) OF OXALIPLATIN PLUS INTRAVENOUS (IV) FLUOROURACIL (FU), LEUCOVORIN (LV) AND CETUXIMAB FOR FIRST-LINE TREATMENT OF UNRESECTABLE COLORECTAL LIVER METASTASES (CRLM): FINAL RESULTS OF A MULTICENTER PHASE 2 STUDY (CHOICE)
    Malka, D.
    Boige, V.
    Faron, M.
    Caramella, C.
    Boucher, E.
    Rivera, P.
    De Baere, T.
    Goere, D.
    Pignon, J.
    Ducreux, M.
    ANNALS OF ONCOLOGY, 2012, 23 : 198 - 198
  • [26] A triplet combination with irinotecan (CPT-11), oxaliplatin (LOHP), continuous infusion 5-fluorouracil and leucovorin (FOLFOXIRI) plus cetuximab as first-line treatment in KRAS wt, metastatic colorectal cancer: a pilot phase II trial
    Saridaki, Z.
    Androulakis, N.
    Vardakis, N.
    Vamvakas, L.
    Kabouraki, E.
    Kalbakis, K.
    Hatzidaki, D.
    Voutsina, A.
    Mavroudis, D.
    Georgoulias, V.
    Souglakos, J.
    BRITISH JOURNAL OF CANCER, 2012, 107 (12) : 1932 - 1937
  • [27] A triplet combination with irinotecan (CPT-11), oxaliplatin (LOHP), continuous infusion 5-fluorouracil and leucovorin (FOLFOXIRI) plus cetuximab as first-line treatment in KRAS wt, metastatic colorectal cancer: a pilot phase II trial
    Z Saridaki
    N Androulakis
    N Vardakis
    L Vamvakas
    E Kabouraki
    K Kalbakis
    D Hatzidaki
    A Voutsina
    D Mavroudis
    V Georgoulias
    J Souglakos
    British Journal of Cancer, 2012, 107 : 1932 - 1937
  • [28] Hepatic arterial infusion (HAT) of oxaliplatin pins intravenous (iv) fluorouracil (FU), leucovorin (LV), and cetuximab for first-line treatment of unresectable colorectal liver metastases (CRLM) (CHOICE): A multicenter phase II study
    Malka, D.
    Paris, E.
    Caramella, C.
    Boucher, E.
    Guimbaud, R.
    Celebic, A.
    De Baere, T.
    Elias, D.
    Pignon, J.
    Ducreux, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [29] Optimal control of liver metastases with intravenous cetuximab and hepatic artery infusion of three-drug chemotherapy in patients with liver-only metastases from colorectal cancer: A European multicenter phase II trial
    Levi, F.
    Bouchahda, M.
    Ducreux, M.
    Karaboue, A.
    Focan, C. N.
    Rougier, P.
    Innominato, P.
    Smith, D.
    Awad, S.
    Adam, R.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [30] Randomized Phase II Study of 5-Fluorouracil Hepatic Arterial Infusion with or without Antineoplastons as an Adjuvant Therapy after Hepatectomy for Liver Metastases from Colorectal Cancer
    Ogata, Yutaka
    Matono, Keiko
    Tsuda, Hideaki
    Ushijima, Masataka
    Uchida, Shinji
    Akagi, Yoshito
    Shirouzu, Kazuo
    PLOS ONE, 2015, 10 (03):
1234